Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-D-glyceric acid -: Selective inhibition by structure-based design

被引:34
|
作者
Ladame, S
Castilho, MS
Silva, CHTP
Denier, C
Hannaert, V
Périé, J
Oliva, G
Willson, M
机构
[1] Univ Toulouse 3, CNRS, UMR 5068, Lab Synth & Physicochim Mol Interet Biol, F-31062 Toulouse, France
[2] Inst Fis Sao Carlos, Sao Carlos, Brazil
[3] Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Trop Dis Res Unit, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 22期
关键词
1,3-bisphospho-D-glyceric acid isosteric analogue; drug design; glyceraldehyde-3-phosphate dehydrogenase (GAPDH); Trypanosoma cruzi;
D O I
10.1046/j.1432-1033.2003.03857.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the first crystal structure of a stable isosteric analogue of 1,3-bisphospho-D-glyceric acid (1,3-BPGA) bound to the catalytic domain of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) in which the two phosphoryl moieties interact with Arg249. This complex possibly illustrates a step of the catalytic process by which Arg249 may induce compression of the product formed, allowing its expulsion from the active site. Structural modifications were introduced into this isosteric analogue and the respective inhibitory effects of the resulting diphosphorylated compounds on T. cruzi and Trypanosoma brucei gGAPDHs were investigated by enzymatic inhibition studies, fluorescence spectroscopy, site-directed mutagenesis, and molecular modelling. Despite the high homology between the two trypanomastid gGAPDHs (>95%), we have identified specific interactions that could be used to design selective irreversible inhibitors against T. cruzi gGAPDH.
引用
收藏
页码:4574 / 4586
页数:13
相关论文
共 21 条
  • [1] Selective inhibition of Trypanosoma brucei GAPDH by 1,3-bisphospho-D-glyceric acid (1,3-diPG) analogues
    Ladame, S
    Bardet, M
    Périé, J
    Willson, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) : 773 - 783
  • [2] Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 Å resolution
    Pavao, F
    Castilho, MS
    Pupo, MT
    Dias, RLA
    Correa, AG
    Fernandes, JB
    da Silva, MFGF
    Mafezoli, J
    Vieira, PC
    Oliva, G
    FEBS LETTERS, 2002, 520 (1-3): : 13 - 17
  • [3] Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase:: structure, catalytic mechanism and targeted inhibitor design
    Souza, DHF
    Garratt, RC
    Araújo, APU
    Guimaraes, BG
    Jesus, WDP
    Michels, PAM
    Hannaert, V
    Oliva, G
    FEBS LETTERS, 1998, 424 (03) : 131 - 135
  • [4] Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design
    Aronov, AM
    Verlinde, CLMJ
    Hol, WGJ
    Gelb, MH
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4790 - 4799
  • [5] Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design
    Bressi, JC
    Verlinde, CLMJ
    Aronov, AM
    Le Shaw, M
    Shin, SS
    Nguyen, LN
    Suresh, S
    Buckner, FS
    Van Voorhis, WC
    Kuntz, ID
    Hol, WGJ
    Gelb, MH
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) : 2080 - 2093
  • [6] Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase
    Aronov, AM
    Suresh, S
    Buckner, FS
    Van Voorhis, WC
    Verlinde, CLMJ
    Opperdoes, FR
    Hol, WGJ
    Gelb, MH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4273 - 4278
  • [7] Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure
    Castilho, MS
    Paváo, F
    Oliva, G
    Ladame, S
    Willson, M
    Périé, J
    BIOCHEMISTRY, 2003, 42 (23) : 7143 - 7151
  • [8] SELECTIVE-INHIBITION OF TRYPANOSOMAL GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE BY PROTEIN STRUCTURE-BASED DESIGN - TOWARD NEW DRUGS FOR THE TREATMENT OF SLEEPING SICKNESS
    VERLINDE, CLMJ
    CALLENS, M
    VANCALENBERGH, S
    VANAERSCHOT, A
    HERDEWIJN, P
    HANNAERT, V
    MICHELS, PAM
    OPPERDOES, FR
    HOL, WGJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3605 - 3613
  • [9] Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica:: Implications for structure-based drug design
    Kundu, Sangeeta
    Roy, Debjani
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2007, 25 (01): : 25 - 33
  • [10] STRUCTURE OF APO T.cruzi GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE: IMPLICATIONS FOR DRUG DESIGN.
    Oliva
    Guimaraes, B. G.
    Delboni, L. F.
    Nonato, M. C.
    Pupo, M. T.
    Pavao, F.
    Mafezolli, J.
    Vieira, P. C.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 267 - 267